Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. 
|Slogan||Touching Lives Over 100 Years|
|Headquarters|| Corporate & Regd. Office
Alembic Road, Vadodara - 390 003, Gujarat,INDIA
Alembic Pharmaceuticals Ltd. initially began as Alembic Chemical Works where it started manufacturing tincture and alcohol at its unit at Vadodara in 1907. The company eventually entered into manufacturing cough syrups, vitamins, tonics and sulphur drugs. Further,Alembic entered into production of penicillin in the 1960s. This dedicated Alembic plant for the manufacture of penicillin was inaugurated by Lal Bahadur Shastri in the year 1961, the then Prime Minister of India. Alembic soon also initiated bulk production of vitamin B12. In the antibiotic section, soon after initiation of penicillin manufacture, Alembic began the production of erythromycin in 1971 for first time in India. Alembic also incorporated and launched the 'Althrocin' brand of erythromycin. In the year, 1997, Althrocin became the top selling brand of erythromycin in India. In 2000, Alembic received ISO 14000 certification for its Vadodara facility. In 2010, Alembic Pharmaceutical Ltd. demerged from Alembic Ltd. subsequent to the allotment of 133,515,914 equity shares of ₹2 each to the shareholders of Alembic Ltd. This made the shareholding of Alembic Ltd. in Alembic Pharmaceutical to reduce from 100% to 29.18%. In 2011, the equity shares of Alembic Pharmaceuticals Ltd. were listed on the Bombay Stock Exchange and National Stock Exchange of India.
The legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.
The publicly listed entity that manufactures and markets generic pharmaceutical products across the globe has grown by leaps and bounds over the last century.
With an emphasis on innovation and technology, the company has established a state-of-the-art research facility – Alembic Research Centre (ARC)-including formulation research, and 150-bed bioequivalence facility at Vadodara, Gujarat. Additionally, APL has recently invested in ultra-modern R&D center at Hyderabad. APL is one of the leading players in the industry to have invested about 11% of its turnover in R&D.
As a growth strategy, the company has aggressively started investing in the international generics market with successful ANDA and DMF filings. APL has also filings across Canada, Europe, Australia, South Africa & Brazil. The company caters to the rest of the world markets through branded formulation sales.
The company aims to explore opportunities in the therapeutic areas such as Dermatology, Oncology, and Injectable Formulations. APL also has also co-promoted a company focused on discovery and development of innovative, small molecule drugs that target signal transduction networks and ion channels for the treatment of cancer, inflammation, autoimmune diseases and metabolic disorders.
"To Improve Healthcare With Innovation, Commitment & Trust."
Rhizen Pharmaceuticals SA
The company Rhizen Pharmaceuticals SA is a limited company established in 2008 and headquartered in La Chaux-de-fonds. Alembic Global Holding SA holds 40.3 % stake in Rhizen Pharmaceuticals SA.
Rhizen is a clinical-stage biopharmaceutical company focused on discovery and development of innovative, small molecule drugs that target signal transduction networks and ion channels for the treatment of cancer, inflammation, autoimmune diseases and metabolic disorders.
Rhizen’s business strategy involves collaborating /licensing with large pharmaceutical companies for late stage clinical development and global marketing while focusing on pushing the research pipeline through preclinical and early human clinical development.
Uday Education Society
Uday Education Society was established in 1959 and is registered under the Bombay Public Trusts Act, 1950 (Bom XXIX of 1950) wide registration no. Baroda F-33 dt. 1st February 1960.
- Alembic Vidyalaya (1959) (Gujarat Secondary Education Board – Gujarati Medium)
- Utkarsh Vidyalaya (1972) (Gujarat Secondary Education Board – Gujarati Medium)
- Tejas Vidyalaya (1984 ) (Gujarat Secondary Education Board – English Medium)
- D. R. Amin Memorial School (1993) (Gujarat Secondary Education Board – English Medium)
Each and every company had been designed with the purpose of committing itself to the best of the domain expertise. In time, we will achieve our goal of being the best at delivering the best. More than a century ago, with the guidance and support of his Highness Maharaja Sayajirao Gaekwad, a great mind with business acumen along with two geniuses of Chemistry, conceived Alembic Chemical Works Company Limited. They were, Prof. T.K. Gajjar – the first renowned chemist in Western India, Prof. Kotibhaskar – a Gold Medalist in Technological Chemistry, and Rajmitra Mr. B. D. Amin – the man with incomparable business tact and capacity for management.
In the year 1907, when Alembic Chemical Works was formed, Prof. Kotibhaskar took the charge of being the Principal Director, Prof. T. K. Gajjar was the organization’s key guidance source. Amidst the two brains of chemistry, Mr. B. D. Amin was at the helm of the affairs for this entity and with his perseverance and dedication, he built the strong foundation of this century-old organization.